Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Hib-MenCY-TT Vaccine in Infants
NCT00289783Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2006
- Primary completion
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of haemophilus influenzae type b capsular polysaccharide meningococcal outer membrane protein conjugate antigen in Haemophilus influenzae type b infection (Hib), meningococcal disease, sponsored by GSK. Started Feb 2006; status: completed.
02
Drugs
haemophilus influenzae type b capsular polysaccharide meningococcal outer membrane protein conjugate antigen
03
Conditions
Haemophilus influenzae type b infection (Hib)meningococcal disease
Beyond the preview
Go deeper on NCT00289783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289783.